Jung C W, Park K T, Kim S Y, Kim S J, Kim M G, Jo S K, Cho W, Kim H K
Department of Surgery, Korea University Anam Hospital, Seoul, Korea.
Transplant Proc. 2013 Oct;45(8):2941-5. doi: 10.1016/j.transproceed.2013.08.048.
This single-center study sought to examine the clinical outcomes of kidney transplant recipients from donors displaying acute kidney injury (AKI).
We analyzed retrospectively the medical records of the donors and recipients of 54 deceased-donor kidney transplantations performed in our center between March 2009 and March 2012.
Among the 54 deceased donors, 36 (66.7%) experienced AKI as determined by the final mean serum creatinine levels measured before graft harvest of 2.66 ± 1.62 mg/dL versus 0.82 ± 0.28 mg/dL among non-AKI donors. The risks of delayed graft function and slow graft function were increased among the AKI versus non-AKI groups in the early post-transplantation period. However, the renal function status of recipients at 3, 6, and 12 months after transplantation was not significantly different between the two groups. Moreover, rejection-free survival rates during the study period were similar. Multivariate analysis revealed an acute rejection episodes (P = .047) and a lower body mass index in the donor relative to the recipient (P = .011) to be independent risk factors predicting poor graft function defined as a 1-year estimated glomerular filtration rate less than 50 mL/min/l.73 m(2). Donor AKI with either a high level (>4.0 mg/dL), an increasing trend of creatinine, or greater severity by the Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) classification was not a significant risk factor.
Transplantation of kidneys from the AKI donors, namely, patients with severely decreased renal function, displayed excellent short-term outcomes. Accordingly, kidney transplantations from deceased donors with AKI should be considered more actively to expand the donor pool in Korea.
本单中心研究旨在探讨来自发生急性肾损伤(AKI)供体的肾移植受者的临床结局。
我们回顾性分析了2009年3月至2012年3月间在本中心进行的54例尸体供肾肾移植供体和受者的医疗记录。
在54例尸体供体中,36例(66.7%)发生了AKI,根据移植前最终平均血清肌酐水平确定,AKI供体为2.66±1.62mg/dL,而非AKI供体为0.82±0.28mg/dL。在移植后早期,AKI组与非AKI组相比,移植肾功能延迟和移植肾功能缓慢的风险增加。然而,两组移植后3个月、6个月和12个月时受者的肾功能状态无显著差异。此外,研究期间的无排斥生存率相似。多因素分析显示,急性排斥反应发作(P = 0.047)以及供体相对于受者较低的体重指数(P = 0.011)是预测移植肾功能不良的独立危险因素,移植肾功能不良定义为1年估计肾小球滤过率低于50mL/min/1.73m²。肌酐水平高(>4.0mg/dL)、肌酐呈上升趋势或根据风险、损伤、衰竭、丧失和终末期肾病(RIFLE)分类具有更高严重程度的供体AKI不是显著危险因素。
来自AKI供体(即肾功能严重下降的患者)的肾脏移植显示出良好的短期结局。因此,在韩国应更积极地考虑接受来自AKI死亡供体的肾脏移植,以扩大供体库。